| 000 | 01625 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250512034506.0 | ||
| 264 | 0 | _c19870624 | |
| 008 | 198706s 0 0 eng d | ||
| 022 | _a0009-7322 | ||
| 024 | 7 |
_a10.1161/01.cir.75.6.1261 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSobel, B E | |
| 245 | 0 | 0 |
_aIntramuscular administration of human tissue-type plasminogen activator in rabbits and dogs and its implications for coronary thrombolysis. _h[electronic resource] |
| 260 |
_bCirculation _cJun 1987 |
||
| 300 |
_a1261-72 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAbsorption |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCapillary Permeability _xdrug effects |
| 650 | 0 | 4 |
_aCoronary Disease _xdrug therapy |
| 650 | 0 | 4 |
_aCoronary Thrombosis _xblood |
| 650 | 0 | 4 | _aDogs |
| 650 | 0 | 4 | _aDrug Evaluation, Preclinical |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aExcipients |
| 650 | 0 | 4 | _aFibrinolytic Agents |
| 650 | 0 | 4 |
_aInjections, Intramuscular _xmethods |
| 650 | 0 | 4 | _aIontophoresis |
| 650 | 0 | 4 | _aRabbits |
| 650 | 0 | 4 |
_aRecombinant Proteins _xadministration & dosage |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aTissue Plasminogen Activator _xadministration & dosage |
| 700 | 1 | _aSaffitz, J E | |
| 700 | 1 | _aFields, L E | |
| 700 | 1 | _aMyears, D W | |
| 700 | 1 | _aSarnoff, S J | |
| 700 | 1 | _aRobison, A K | |
| 700 | 1 | _aOwensby, D A | |
| 700 | 1 | _aFox, K A | |
| 773 | 0 |
_tCirculation _gvol. 75 _gno. 6 _gp. 1261-72 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1161/01.cir.75.6.1261 _zAvailable from publisher's website |
| 999 |
_c3111719 _d3111719 |
||